News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH
Photo taken from Dana-Farber’s Breast Oncology Center/X
Apr 8, 2024, 14:26

Dana-Farber’s Breast Oncology Center is leading a trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH

Dana-Farber’s Breast Oncology Center posted on X:

“We are leading a randomized Phase 2 trial for stage 1 HER2+ Breast Cancer of T-DM1 followed by SQ trastuzumab versus TH (paclitaxel + SQ trastuzumab) (ATEMPT 2.0).”

Read further.
Source: Dana-Farber’s Breast Oncology Center/X

Breast Cancer cancer clinical trial Dana-Farber Cancer Center Dana-Farber’s Breast Oncology Center HER2+ breast cancer OncoDaily Oncology Paclitaxel trastuzumab
Special Coverage
Drugs
Apr 25, 2025, 05:55
Durvalumab (Imfinzi): What patients need to know?
Blog
Apr 25, 2025, 05:27
Applications are still open for The SIOG Advanced Course 2025
Career
Apr 25, 2025, 04:25
Cary Adams endorses Dato' Dr Saunthari Somasundaram as the candidate for the President-elect for the NCD Alliance
Oncolibrary
Apr 25, 2025, 02:46
FDA Approves Penpulimab for Recurrent or Metastatic Non-Keratinizing Nasopharyngeal Carcinoma
Career
Apr 24, 2025, 21:39
Triparna Sen: I am thrilled and humbled to be nominated as a candidate for the IASLC Board of Directors
Blog
Apr 24, 2025, 21:05
Liz O’Riordan: 25 things I wish I had known before I got breast cancer
Blog
Apr 24, 2025, 20:53
Signing Ceremony of MoU Between Doha University for Science and Technology and Qatar Cancer Society
Blog
Apr 24, 2025, 20:40
Yan Leyfman: How AI is transforming cancer care - from improving diagnosis to reducing disparities
Insight
Apr 24, 2025, 20:28
Fernando Campos: We revealed a harsh Brazilian reality in Sarcoma Study
Insight
Apr 24, 2025, 19:38
George Vlachogiannis: Black patients were less likely to receive nephrectomy compared to non-Hispanic White patients
Blog
Apr 24, 2025, 18:30
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Blog
Apr 24, 2025, 17:56
Milestones from Philippine Cervical Cancer Elimination Operational Plan Workshop - APAC Women's Cancer Coalition